Cargando…
Use of lipid-lowering therapy after ischaemic stroke and expected benefit from intensification of treatment
OBJECTIVES: Elevated low-density lipoprotein cholesterol (LDL-C) increases the risk of recurrent cardiovascular disease (CVD) events. We examined use of lipid-lowering therapy (LLT) following ischaemic stroke, and estimated benefits from guideline-based up-titration of LLT. METHODS: The Norwegian CO...
Autores principales: | Gynnild, Mari Nordbø, Hageman, Steven H J, Spigset, Olav, Lydersen, Stian, Saltvedt, Ingvild, Dorresteijn, Jannick A N, Visseren, Frank L J, Ellekjær, Hanne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9036470/ https://www.ncbi.nlm.nih.gov/pubmed/35459718 http://dx.doi.org/10.1136/openhrt-2022-001972 |
Ejemplares similares
-
Risk Stratification in Patients with Ischemic Stroke and Residual Cardiovascular Risk with Current Secondary Prevention
por: Gynnild, Mari Nordbø, et al.
Publicado: (2021) -
Tea consumption and risk of ischaemic heart disease
por: Li, Xia, et al.
Publicado: (2017) -
Right atrium and cryptogenic ischaemic stroke in the young: a case–control study
por: Pöyhönen, Pauli, et al.
Publicado: (2021) -
Interstitial lung disease is a risk factor for ischaemic heart disease and myocardial infarction
por: Clarson, Lorna Elise, et al.
Publicado: (2020) -
Association of the Robert Wood Johnson Foundations’ social determinants of health and Medicare hospitalisations for ischaemic strokes: a cross-sectional data analysis
por: Wang, Andrew, et al.
Publicado: (2020)